Peter Attia· MD
even in secondary prevention studies of individuals who have post myocardial infarction you know young women under the age of 55 were significantly less likely than men to be on a Statin you know two months after their Mi
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
even in secondary prevention studies of individuals who have post myocardial infarction you know young women under the age of 55 were significantly less likely than men to be on a Statin you know two months after their Mi
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
women are less likely to be offered a Statin we saw this from the Palm registry and if offered women are more likely to decline or discontinue
but despite the evidence clearly showing that they benefit to get back to your original question women are less likely to be offered a Statin we saw this from the Palm registry